HASS Corp. (KOSDAQ:450330)

Market Cap	60.96B
Revenue (ttm)	15.17B
Net Income (ttm)	383.47M
Shares Out	7.84M
EPS (ttm)	48.15
PE Ratio	161.58
Forward PE	n/a
Dividend	70.00 (0.90%)
Ex-Dividend Date	n/a

Volume	14,476
Average Volume	17,761
Open	7,700.00
Previous Close	7,780.00
Day's Range	7,700.00 - 7,900.00
52-Week Range	6,550.00 - 13,910.00
Beta	n/a
RSI	46.77
Earnings Date	Aug 29, 2025

About Turnstone Biologics

Hass Corp. manufactures and sells dental medical devices. Its CAD/CAM systems include Amber Mill, a machinable dental glass-ceramic blocks made of lithium disilicate; Amber Mill Direct, a CAD/CAM-based millable lithium disilicate block; Amber Mill H, a CAD/CAM block using nano-crystalline ceramics particle; Amber Mill Q, an implant abutment solution; and Amber Mill Meso, a lithium disilicate-based block for implant prosthese. The company’s heat-pressing systems comprise Amber Press, a lithium disilicate-based press ingots; Amber Press Master, a...

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 2008
• Employees: 106
• Stock Exchange: KOSDAQ
• Ticker Symbol: 450330

Financial Performance

In 2024, HASS Corp.'s revenue was 16.16 billion, an increase of 0.78% compared to the previous year's 16.04 billion. Earnings were 1.79 billion, a decrease of -0.25%.